Utility of patient-specific human iPSC-derived nodal- and working-type ventricular cardiomyocytes to model a novel combined electromechanical cardiac disorder caused by mutations in HCN4
| Institution | Ruprecht-Karls-Universität Heidelberg |
|---|---|
| Projektleiter | Patrick Schweizer |
| Standort | Heidelberg/Mannheim |
| Projektart | Shared Expertise (SE) |
| Fördersumme | € 38.200,00 |
| Beginn | 01.01.2020 |
| Ende | 31.12.2022 |
| Partnerprojekte |
Förderkennzeichen
81X2500186
Projektnummer
1214